ADVANCED ENZYME TECHNOLOGIES
Back to Balance Sheet
|
ADVANCED ENZYME TECHNOLOGIES Last 5 Year Total Debt History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Debt | ₹21 Cr | ₹22 Cr | ₹25 Cr | ₹13 Cr | ₹11 Cr |
What is the latest Total Debt ratio of ADVANCED ENZYME TECHNOLOGIES ?
| Year | Total Debt |
|---|---|
| Mar2026 | ₹21 Cr |
| Mar2025 | ₹22 Cr |
| Mar2024 | ₹25 Cr |
| Mar2023 | ₹13 Cr |
| Mar2022 | ₹11 Cr |
How is Total Debt of ADVANCED ENZYME TECHNOLOGIES Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2026 | ₹21 Cr | -4.68 | |
| Mar2025 | ₹22 Cr | -14.24 | |
| Mar2024 | ₹25 Cr | 89.68 | |
| Mar2023 | ₹13 Cr | 21.01 | |
| Mar2022 | ₹11 Cr | - | |
Compare Total Debt of peers of ADVANCED ENZYME TECHNOLOGIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ADVANCED ENZYME TECHNOLOGIES | ₹3,025.1 Cr | -3.8% | -8% | -15.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,861.0 Cr | -2% | -6.1% | 12.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹254,319.0 Cr | 3.2% | 5.3% | 67.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,153.0 Cr | -1.9% | -2.9% | 32.7% | Stock Analytics | |
| CIPLA | ₹107,406.0 Cr | -1.5% | -4% | -10.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,362.0 Cr | -2.7% | 4.2% | -1.2% | Stock Analytics | |
ADVANCED ENZYME TECHNOLOGIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ADVANCED ENZYME TECHNOLOGIES | -3.8% |
-8% |
-15.9% |
| SENSEX | 0.2% |
-4.6% |
-9.6% |
You may also like the below Video Courses